Assessment of Quizartinib Pharmacokinetic in Subjects With Severe Hepatic Impairment

Clinical trial NCT06740799 · RECRUITING

Trial details

NCT number: NCT06740799
Sponsor: Daiichi Sankyo
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Hepatic Impairment

Start date: 2024-09-30
Primary completion: 2026-10-31
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.